SCHEMBL6583460

SCHEMBL6583460

CC(C)[Si](Oc1ccc2ccc[c]c2c1)(C(C)C)C(C)C

nearest known ligand 0.31

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.31
CYP2A6 P11509 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7197663 0.82 CYP1A2 (0.33) CYP1A2CYP2A6
SCHEMBL31670075 0.78 CYP2A6 (0.52) CYP1A2CYP2A6
SCHEMBL645480 0.76 CYP1A2 (0.55) CYP1A2CYP2A6
SCHEMBL2251601 0.72 NQO1 (0.43) CYP1A2
SCHEMBL23413070 0.70 CYP3A4 (0.51) CYP1A2
SCHEMBL15298750 0.69 CYP1A2 (0.50) CYP1A2CYP2A6
SCHEMBL28166206 0.69 UGT2B7 (0.41) CYP1A2
SCHEMBL7199090 0.69 CYP1A2 (0.33) CYP1A2CYP2A6
SCHEMBL5543057 0.69 GPR3 (0.40) CYP1A2
SCHEMBL6417161 0.69 HTR2A (0.35) CYP1A2CYP2A6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1414788-A1 NAPHTHYLUREA AND NAPHTHYLACETAMIDE DERIVATIVES AS VANILLOID RECEPTOR 1 (VR1) ANTAGONISTS Bayer HealthCare AG (DE) 2004-05-06 EP disclosed
WO-2003014064-A1 NAPHTHYLUREA AND NAPHTHYLACETAMIDE DERIVATIVES AS VANILLOID RECEPTOR 1 (VR1) ANTAGONISTS BAYER HEALTHCARE AG (DE) 2003-02-20 WO disclosed